Our work is currently funded through the following sources:
- Starting in May 2021:
-
- Open call on personalized breast cancer treatments from the Rosa sløfe (Pink Ribbon) campaign, Norwegian Cancer Society, for the project “Cis-regulatory signatures for improved identification and stratification of breast cancer subtypes”: NOK 4.999 millions over 4 years
- Since August 2019:
- Young Research Talents grant from the Research Council of Norway for the project “Characterisation of cis-regulatory variations that dysregulate driver microRNAs in cancer”: NOK 7.352 millions over 3 years
- Open Call grant from the Norwegian Cancer Society for the project “Characterisation of cis-regulatory variations that dysregulate driver microRNAs in cancer”: 1.968 millions over 4 years
- Young Research Talents grant from the Research Council of Norway for the project “Characterisation of cis-regulatory variations that dysregulate driver microRNAs in cancer”: NOK 7.352 millions over 3 years
- Since May 2016:
- Research Council of Norway (project #187615), Helse-Sør Øst, and the University of Oslo through the Centre for Molecular Medicine Norway (NCMM): NOK 18M over 5 years as start-up package to launch the Computational Biology & Gene Regulation Group.
